Why would these comments come out if this was not a positive announcement?
Director of Dermatology, Clinical studies and Division Head of Dermatology at Henry Ford Health System in Michigan USA, Dr Linda Stein Gold commented: “The safety and efficacy outcomes provide confidence that synthetic cannabidiol can represent an exciting new treatment option for acne patients. “The effect on comedones (inflammatory lesions) is particularly pleasing, given BTX 1503’s proposed mechanisms on the underlying causes of acne including inflammation and bacterial infection.”
Australian investigator and Fellow of the Australasian College of Dermatologists, Dr Catherine Reid: “Patients found PermetrexTM enabled BTX 1503 easy to apply, it was not sticky and didn’t burn or sting.” “We are pleased to have contributed to this study and are excited by the potential of BTX 1503 and we look forward to participating in the Phase 3 study program.”
- Forums
- ASX - By Stock
- BOT
- Ann: Botanix Announces BTX 1503 Data and Progression to Phase 3
Ann: Botanix Announces BTX 1503 Data and Progression to Phase 3, page-126
-
- There are more pages in this discussion • 277 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $669.7M |
Open | High | Low | Value | Volume |
37.5¢ | 37.5¢ | 35.0¢ | $2.942M | 8.074M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 209912 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 348505 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 248535 | 0.370 |
16 | 235980 | 0.365 |
11 | 388796 | 0.360 |
11 | 926849 | 0.355 |
11 | 831727 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 348494 | 8 |
0.380 | 529269 | 19 |
0.385 | 207424 | 8 |
0.390 | 723886 | 12 |
0.395 | 352644 | 12 |
Last trade - 15.00pm 15/07/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online